Applied Therapeutics Inc. announced that the appointment of Dr. Riccardo Perfetti to the position of Chief Medical Officer. Dr. Perfetti is a distinguished endocrinologist with more than 15 years' experience in drug development. Prior to joining the company, Dr. Perfetti served as Senior Medical Officer and Vice President, Head of Global Medical Affairs, Diabetes and Cardiovascular Business Unit at Sanofi. Additionally, the company announced the addition of two distinguished clinicians to the company's Scientific Advisory Board: Dr. Donald D'Amico, MD, Chairman of Ophthalmology at Weill Cornell Medical College and Ophthalmologist-in-Chief at the New York Presbyterian Hospital, and Dr. Eric Kanter, partner at Retina-Vitreous Consultants. Dr. D'Amico and Dr. Kanter will serve in an expert advisory capacity to support the development of Applied Therapeutics's diabetic retinopathy program.